Which has preferable earnings & valuation, LH or HIMS?

Labcorp has higher revenue and earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Labcorp, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Labcorp $13.95B 1.85 $876.50M $12.09 26.30 Hims & Hers Health $2.35B 2.80 $128.37M -$0.63 N/A

Does the media prefer LH or HIMS?

In the previous week, Hims & Hers Health had 44 more articles in the media than Labcorp. MarketBeat recorded 53 mentions for Hims & Hers Health and 9 mentions for Labcorp. Labcorp's average media sentiment score of 0.68 beat Hims & Hers Health's score of 0.00 indicating that Labcorp is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Labcorp 4 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Hims & Hers Health 6 Very Positive mention(s) 7 Positive mention(s) 20 Neutral mention(s) 12 Negative mention(s) 2 Very Negative mention(s) Neutral

Does the media prefer DGX or HIMS?

In the previous week, Hims & Hers Health had 34 more articles in the media than Quest Diagnostics. MarketBeat recorded 53 mentions for Hims & Hers Health and 19 mentions for Quest Diagnostics. Quest Diagnostics' average media sentiment score of 0.93 beat Hims & Hers Health's score of 0.00 indicating that Quest Diagnostics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Quest Diagnostics 4 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Hims & Hers Health 6 Very Positive mention(s) 7 Positive mention(s) 20 Neutral mention(s) 12 Negative mention(s) 2 Very Negative mention(s) Neutral

Does the media refer more to GH or HIMS?

In the previous week, Hims & Hers Health had 39 more articles in the media than Guardant Health. MarketBeat recorded 53 mentions for Hims & Hers Health and 14 mentions for Guardant Health. Guardant Health's average media sentiment score of 0.99 beat Hims & Hers Health's score of 0.00 indicating that Guardant Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardant Health 8 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Hims & Hers Health 6 Very Positive mention(s) 7 Positive mention(s) 20 Neutral mention(s) 12 Negative mention(s) 2 Very Negative mention(s) Neutral

Does the media refer more to FMS or HIMS?

In the previous week, Hims & Hers Health had 50 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 53 mentions for Hims & Hers Health and 3 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.44 beat Hims & Hers Health's score of 0.00 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Fresenius Medical Care AG & Co. KGaA 1 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Hims & Hers Health 6 Very Positive mention(s) 7 Positive mention(s) 20 Neutral mention(s) 12 Negative mention(s) 2 Very Negative mention(s) Neutral

Does the media favor HIMS or BTSG?

In the previous week, Hims & Hers Health had 41 more articles in the media than BrightSpring Health Services. MarketBeat recorded 53 mentions for Hims & Hers Health and 12 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 0.77 beat Hims & Hers Health's score of 0.00 indicating that BrightSpring Health Services is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hims & Hers Health 6 Very Positive mention(s) 7 Positive mention(s) 20 Neutral mention(s) 12 Negative mention(s) 2 Very Negative mention(s) Neutral BrightSpring Health Services 6 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Hims & Hers Health (HIMS) Competitors

$28.15 -0.62 (-2.15%)

Closing price 08/14/2026 03:59 PM Eastern

Extended Trading

$28.19 +0.04 (+0.13%)

As of 08/14/2026 08:00 PM Eastern

Compare

HIMS vs. LH, DGX, GH, FMS, and BTSG

Should you buy Hims & Hers Health stock or one of its competitors? Hims & Hers Health's main competitors and comparable companies include Labcorp (LH), Quest Diagnostics (DGX), Guardant Health (GH), Fresenius Medical Care AG & Co. KGaA (FMS), and BrightSpring Health Services (BTSG). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Hims & Hers Health compare to Labcorp?

Labcorp (NYSE:LH) and Hims & Hers Health (NYSE:HIMS) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, media sentiment, profitability, institutional ownership, earnings and valuation.

Labcorp has a net margin of 6.99% compared to Hims & Hers Health's net margin of -5.51%. Labcorp's return on equity of 16.74% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Labcorp	6.99%	16.74%	7.81%
Hims & Hers Health	-5.51%	-6.51%	-1.20%

Labcorp currently has a consensus price target of $330.00, indicating a potential upside of 3.77%. Hims & Hers Health has a consensus price target of $32.43, indicating a potential upside of 15.21%. Given Hims & Hers Health's higher probable upside, analysts plainly believe Hims & Hers Health is more favorable than Labcorp.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Labcorp	0 Sell rating(s)	3 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.75
Hims & Hers Health	1 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.19

In the previous week, Hims & Hers Health had 44 more articles in the media than Labcorp. MarketBeat recorded 53 mentions for Hims & Hers Health and 9 mentions for Labcorp. Labcorp's average media sentiment score of 0.68 beat Hims & Hers Health's score of 0.00 indicating that Labcorp is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Labcorp	4 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Hims & Hers Health	6 Very Positive mention(s)	7 Positive mention(s)	20 Neutral mention(s)	12 Negative mention(s)	2 Very Negative mention(s)	Neutral

95.9% of Labcorp shares are owned by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are owned by institutional investors. 0.8% of Labcorp shares are owned by insiders. Comparatively, 11.8% of Hims & Hers Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Labcorp has a beta of 0.87, meaning that its stock price is 13% less volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.4, meaning that its stock price is 140% more volatile than the broader market.

Labcorp has higher revenue and earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Labcorp, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Labcorp	$13.95B	1.85	$876.50M	$12.09	26.30
Hims & Hers Health	$2.35B	2.80	$128.37M	-$0.63	N/A

Summary

Labcorp beats Hims & Hers Health on 11 of the 16 factors compared between the two stocks.

How does Hims & Hers Health compare to Quest Diagnostics?

Quest Diagnostics (NYSE:DGX) and Hims & Hers Health (NYSE:HIMS) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, profitability, institutional ownership, earnings, dividends, risk and analyst recommendations.

Quest Diagnostics has higher revenue and earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Quest Diagnostics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Quest Diagnostics	$11.04B	2.35	$992M	$9.42	24.89
Hims & Hers Health	$2.35B	2.80	$128.37M	-$0.63	N/A

In the previous week, Hims & Hers Health had 34 more articles in the media than Quest Diagnostics. MarketBeat recorded 53 mentions for Hims & Hers Health and 19 mentions for Quest Diagnostics. Quest Diagnostics' average media sentiment score of 0.93 beat Hims & Hers Health's score of 0.00 indicating that Quest Diagnostics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Quest Diagnostics	4 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Hims & Hers Health	6 Very Positive mention(s)	7 Positive mention(s)	20 Neutral mention(s)	12 Negative mention(s)	2 Very Negative mention(s)	Neutral

Quest Diagnostics has a net margin of 9.18% compared to Hims & Hers Health's net margin of -5.51%. Quest Diagnostics' return on equity of 16.01% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Quest Diagnostics	9.18%	16.01%	7.27%
Hims & Hers Health	-5.51%	-6.51%	-1.20%

Quest Diagnostics has a beta of 0.56, indicating that its stock price is 44% less volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.4, indicating that its stock price is 140% more volatile than the broader market.

Quest Diagnostics presently has a consensus target price of $235.31, suggesting a potential upside of 0.35%. Hims & Hers Health has a consensus target price of $32.43, suggesting a potential upside of 15.21%. Given Hims & Hers Health's higher possible upside, analysts plainly believe Hims & Hers Health is more favorable than Quest Diagnostics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Quest Diagnostics	0 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.54
Hims & Hers Health	1 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.19

88.1% of Quest Diagnostics shares are owned by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are owned by institutional investors. 0.9% of Quest Diagnostics shares are owned by company insiders. Comparatively, 11.8% of Hims & Hers Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Quest Diagnostics beats Hims & Hers Health on 12 of the 17 factors compared between the two stocks.

How does Hims & Hers Health compare to Guardant Health?

Guardant Health (NASDAQ:GH) and Hims & Hers Health (NYSE:HIMS) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, profitability, valuation and dividends.

Hims & Hers Health has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guardant Health	$982.02M	21.48	-$416.28M	-$3.49	N/A
Hims & Hers Health	$2.35B	2.80	$128.37M	-$0.63	N/A

Hims & Hers Health has a net margin of -5.51% compared to Guardant Health's net margin of -38.33%. Guardant Health's return on equity of 0.00% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Guardant Health	-38.33%	N/A	-25.40%
Hims & Hers Health	-5.51%	-6.51%	-1.20%

92.6% of Guardant Health shares are owned by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are owned by institutional investors. 5.6% of Guardant Health shares are owned by company insiders. Comparatively, 11.8% of Hims & Hers Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Guardant Health has a beta of 1.6, meaning that its share price is 60% more volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.4, meaning that its share price is 140% more volatile than the broader market.

Guardant Health presently has a consensus price target of $183.78, suggesting a potential upside of 16.90%. Hims & Hers Health has a consensus price target of $32.43, suggesting a potential upside of 15.21%. Given Guardant Health's stronger consensus rating and higher possible upside, equities research analysts plainly believe Guardant Health is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardant Health	1 Sell rating(s)	0 Hold rating(s)	23 Buy rating(s)	1 Strong Buy rating(s)	2.96
Hims & Hers Health	1 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.19

In the previous week, Hims & Hers Health had 39 more articles in the media than Guardant Health. MarketBeat recorded 53 mentions for Hims & Hers Health and 14 mentions for Guardant Health. Guardant Health's average media sentiment score of 0.99 beat Hims & Hers Health's score of 0.00 indicating that Guardant Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Guardant Health	8 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Hims & Hers Health	6 Very Positive mention(s)	7 Positive mention(s)	20 Neutral mention(s)	12 Negative mention(s)	2 Very Negative mention(s)	Neutral

Summary

Hims & Hers Health beats Guardant Health on 9 of the 17 factors compared between the two stocks.

How does Hims & Hers Health compare to Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and Hims & Hers Health (NYSE:HIMS) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, media sentiment, profitability, dividends, analyst recommendations, risk, valuation and institutional ownership.

Fresenius Medical Care AG & Co. KGaA has a beta of 0.77, indicating that its stock price is 23% less volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.4, indicating that its stock price is 140% more volatile than the broader market.

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Fresenius Medical Care AG & Co. KGaA, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.57	$1.11B	$1.93	12.31
Hims & Hers Health	$2.35B	2.80	$128.37M	-$0.63	N/A

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.83% compared to Hims & Hers Health's net margin of -5.51%. Fresenius Medical Care AG & Co. KGaA's return on equity of 9.28% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fresenius Medical Care AG & Co. KGaA	4.83%	9.28%	4.16%
Hims & Hers Health	-5.51%	-6.51%	-1.20%

8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are held by institutional investors. 11.8% of Hims & Hers Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Fresenius Medical Care AG & Co. KGaA presently has a consensus price target of $23.57, indicating a potential downside of 0.77%. Hims & Hers Health has a consensus price target of $32.43, indicating a potential upside of 15.21%. Given Hims & Hers Health's stronger consensus rating and higher possible upside, analysts clearly believe Hims & Hers Health is more favorable than Fresenius Medical Care AG & Co. KGaA.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fresenius Medical Care AG & Co. KGaA	5 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.55
Hims & Hers Health	1 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.19

In the previous week, Hims & Hers Health had 50 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 53 mentions for Hims & Hers Health and 3 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.44 beat Hims & Hers Health's score of 0.00 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Fresenius Medical Care AG & Co. KGaA	1 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Hims & Hers Health	6 Very Positive mention(s)	7 Positive mention(s)	20 Neutral mention(s)	12 Negative mention(s)	2 Very Negative mention(s)	Neutral

Summary

Fresenius Medical Care AG & Co. KGaA and Hims & Hers Health tied by winning 8 of the 16 factors compared between the two stocks.

How does Hims & Hers Health compare to BrightSpring Health Services?

Hims & Hers Health (NYSE:HIMS) and BrightSpring Health Services (NASDAQ:BTSG) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, media sentiment, dividends, profitability, institutional ownership, analyst recommendations, risk and valuation.

BrightSpring Health Services has higher revenue and earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$2.35B	2.80	$128.37M	-$0.63	N/A
BrightSpring Health Services	$12.91B	0.95	$190.67M	$1.66	37.17

Hims & Hers Health has a beta of 2.4, meaning that its stock price is 140% more volatile than the broader market. Comparatively, BrightSpring Health Services has a beta of 1.88, meaning that its stock price is 88% more volatile than the broader market.

Hims & Hers Health currently has a consensus target price of $32.43, suggesting a potential upside of 15.21%. BrightSpring Health Services has a consensus target price of $70.71, suggesting a potential upside of 14.58%. Given Hims & Hers Health's higher possible upside, research analysts clearly believe Hims & Hers Health is more favorable than BrightSpring Health Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	1 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.19
BrightSpring Health Services	0 Sell rating(s)	0 Hold rating(s)	18 Buy rating(s)	2 Strong Buy rating(s)	3.10

BrightSpring Health Services has a net margin of 2.55% compared to Hims & Hers Health's net margin of -5.51%. BrightSpring Health Services' return on equity of 16.73% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	-5.51%	-6.51%	-1.20%
BrightSpring Health Services	2.55%	16.73%	5.24%

63.5% of Hims & Hers Health shares are held by institutional investors. 11.8% of Hims & Hers Health shares are held by company insiders. Comparatively, 2.8% of BrightSpring Health Services shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Hims & Hers Health had 41 more articles in the media than BrightSpring Health Services. MarketBeat recorded 53 mentions for Hims & Hers Health and 12 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 0.77 beat Hims & Hers Health's score of 0.00 indicating that BrightSpring Health Services is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hims & Hers Health	6 Very Positive mention(s)	7 Positive mention(s)	20 Neutral mention(s)	12 Negative mention(s)	2 Very Negative mention(s)	Neutral
BrightSpring Health Services	6 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

BrightSpring Health Services beats Hims & Hers Health on 11 of the 17 factors compared between the two stocks.

Get Hims & Hers Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HIMS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HIMS vs. The Competition

Export

Metric	Hims & Hers Health	Healthcare Providers & Services Industry	Healthcare Sector	NYSE Exchange
Market Cap	$6.57B	$9.87B	$7.03B	$24.33B
Dividend Yield	N/A	2.54%	2.57%	3.68%
P/E Ratio	-44.68	35.17	271.26	30.85
Price / Sales	2.80	4.88	622.47	18.02
Price / Cash	33.64	124.24	75.70	32.61
Price / Book	20.25	3.94	12.92	6.82
Net Income	$128.37M	$309.96M	$3.45B	$1.06B
7 Day Performance	-10.86%	0.09%	1.16%	0.55%
1 Month Performance	-16.29%	-0.34%	2.17%	2.70%
1 Year Performance	-38.92%	19.48%	62.38%	19.14%

Hims & Hers Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HIMS Hims & Hers Health	2.4336 of 5 stars	$28.15 -2.2%	$32.43 +15.2%	-38.9%	$6.57B	$2.35B	N/A	2,442	Trending News Earnings Report Analyst Forecast
LH Labcorp	4.1419 of 5 stars	$321.82 +0.2%	$330.00 +2.5%	+17.5%	$26.43B	$14.35B	26.66	71,000	Insider Trade
DGX Quest Diagnostics	4.3989 of 5 stars	$237.27 -0.2%	$235.31 -0.8%	+30.5%	$26.31B	$11.04B	25.31	57,000	Trending News Dividend Announcement Analyst Upgrade Analyst Revision
GH Guardant Health	3.214 of 5 stars	$164.83 -1.4%	$183.78 +11.5%	+167.0%	$22.18B	$982.02M	N/A	2,506	Positive News Insider Trade
FMS Fresenius Medical Care AG & Co. KGaA	3.1543 of 5 stars	$23.90 -1.9%	$23.57 -1.4%	-5.3%	$12.85B	$19.43B	12.40	1,488	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:HIMS) was last updated on 8/16/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Hims & Hers Health (HIMS) Competitors

HIMS vs. LH, DGX, GH, FMS, and BTSG

How does Hims & Hers Health compare to Labcorp?

Summary

How does Hims & Hers Health compare to Quest Diagnostics?

Summary

How does Hims & Hers Health compare to Guardant Health?

Summary

How does Hims & Hers Health compare to Fresenius Medical Care AG & Co. KGaA?

Summary

How does Hims & Hers Health compare to BrightSpring Health Services?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HIMS vs. The Competition

Hims & Hers Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Hims & Hers Health (HIMS) Competitors

HIMS vs. LH, DGX, GH, FMS, and BTSG

How does Hims & Hers Health compare to Labcorp?

Is LH or HIMS more profitable?

Do analysts rate LH or HIMS?

Does the media prefer LH or HIMS?

Do insiders and institutionals believe in LH or HIMS?

Which has more volatility and risk, LH or HIMS?

Which has preferable earnings & valuation, LH or HIMS?

Summary

How does Hims & Hers Health compare to Quest Diagnostics?

Which has better valuation and earnings, DGX or HIMS?

Does the media prefer DGX or HIMS?

Is DGX or HIMS more profitable?

Which has more volatility & risk, DGX or HIMS?

Do analysts prefer DGX or HIMS?

Do insiders and institutionals have more ownership in DGX or HIMS?

Summary

How does Hims & Hers Health compare to Guardant Health?

Which has higher valuation and earnings, GH or HIMS?

Is GH or HIMS more profitable?

Do insiders and institutionals hold more shares of GH or HIMS?

Which has more volatility & risk, GH or HIMS?

Do analysts prefer GH or HIMS?

Does the media refer more to GH or HIMS?

Summary

How does Hims & Hers Health compare to Fresenius Medical Care AG & Co. KGaA?

Which has more volatility & risk, FMS or HIMS?

Which has preferable earnings & valuation, FMS or HIMS?

Is FMS or HIMS more profitable?

Do institutionals and insiders believe in FMS or HIMS?

Do analysts recommend FMS or HIMS?

Does the media refer more to FMS or HIMS?

Summary

How does Hims & Hers Health compare to BrightSpring Health Services?

Which has stronger earnings & valuation, HIMS or BTSG?

Which has more volatility & risk, HIMS or BTSG?

Do analysts prefer HIMS or BTSG?

Is HIMS or BTSG more profitable?

Do institutionals and insiders have more ownership in HIMS or BTSG?

Does the media favor HIMS or BTSG?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HIMS vs. The Competition

Hims & Hers Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools